Ongoing research is exploring the potential of NMDA receptor antagonists in treating various neuropsychiatric disorders, such as schizophrenia and bipolar disorder. These studies aim to develop drugs that maximize therapeutic outcomes while minimizing adverse effects. Understanding the molecular mechanisms and pathways involved in NMDA receptor modulation could lead to the development of safer and more effective treatments.
